shopping cart
more
The Click Chemistry Platform
Interesting Life Sciences News
01st November 2018
llumina acquires Pacific Biosciences for approximately $1.2 Billion
16th August 2018
BioNTech enters into collaborationship with Pfizer on the development of influenza preventing mRNA-based vaccines.
10th August 2018
FDA approves first siRNA drug “Onpattro” (Alnylam Pharmaceuticals, Inc.) for the treatment of polyneuropathy in adult patients.
llumina acquires Pacific Biosciences for approximately $1.2 Billion
16th August 2018
BioNTech enters into collaborationship with Pfizer on the development of influenza preventing mRNA-based vaccines.
10th August 2018
FDA approves first siRNA drug “Onpattro” (Alnylam Pharmaceuticals, Inc.) for the treatment of polyneuropathy in adult patients.
Our Mission, Technology & Key Products
As leading pioneer in high-end nucleic acid modification & conjugation, we understand ourselves as transformative enabler for the development of new and value added applications, e.g. single-molecule NGS sequencing, best-in-class cell proliferation tests, engineered mRNA,…
Based on our perfected bioconjugation concept, we offer ready-to-use clickable products, custom oligos as well as our powerful technology next to product development services.